leukemia
Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic
The two companies will codevelop the next-generation sequencing test for Kartos's MDM2 inhibitor, KRT-232, being studied in TP53 wild-type blood cancers.
COVID-19 Pandemic Changing Digital Innovations, Care Models for Lab Industry, Panelists Say at ACLA
Premium
At ACLA's annual meeting, a panel discussed how machine learning, artificial intelligence, telehealth, and at-home testing have gained traction throughout the laboratory industry.
Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials
Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials.
Cepheid Developing New Target for BCR-ABL Test for Leukemia Patients
The firm's new application of its BCR-ABL test will be able to detect p190 transcripts and is currently for research use only.
Clinical Genomics Nabs Medicare Coverage for Colorectal Cancer Test as Novitas Revises LCD
Novitas added multiple leukemia biomarkers to its coverage determination, as well as the ThyGeNEXT molecular panel.
May 12, 2020
Adaptive Biotechnologies Q1 Revenues Grow 65 Percent
Feb 27, 2020
NeoGenomics Q4 Revenue Up 40 Percent
Feb 26, 2020
Adaptive Biotechnologies Q4 Revenues Rise 41 Percent
Dec 17, 2019
Dec 4, 2019
Aug 14, 2019